rfxcel, Whose Technology Serializes 70% of Russia’s Pharma Market, Quickly Adapts to Major Changes to Reporting Requirements
Russia’s Drug Circulation Monitoring System (MDLP) has developed new reporting requirements after experiencing technical problems that created serious issues in the country’s pharma supply chain. One of the most important changes is to Form 703, which facilitates foreign importation to Russia.
As the leader in Russian compliance, we acted immediately and now support the MDLP’s new transaction requirements. To learn more about the changes and how to comply with Russia’s strict track and trace requirements, contact Victoria Kozlova, rfxcel’s General Director in Moscow, at email@example.com.